Basic information:

CAS number: 1208243-50-8.

Molecular formula: C₅₁H₈₄N₁₆O₂₁.

Molecular weight: 1257.31.

Mechanism of action: ARA-290 selectively interacts with innate repair receptors, which are only expressed when tissues are damaged or stressed. After ARA-290 activates the innate repair receptors, it shuts down the inflammatory response and starts the body's natural repair system, thereby mediating tissue repair and regeneration, reducing inflammation and cell apoptosis.

Potential effects:

Improving metabolism: Relevant clinical studies have shown that ARA-290 helps reduce the level of glycated hemoglobin A1c in patients with type 2 diabetes, improves blood lipid status, and has a positive effect on the metabolic control of diabetic patients.

Relieve neuropathic pain: It can significantly improve the symptoms of neuropathic pain in diabetic patients. By increasing the density of corneal nerve fibers and promoting nerve regeneration, it helps to relieve nerve pain and enhance sensory function.

Tissue protection and repair: It has neuroprotective effects, can enhance the proliferation and migration ability of endothelial colony-forming cells, improve cell resistance to apoptosis, and improve angiogenesis. It has potential therapeutic value in neurological diseases.

Dosage: It is usually administered by subcutaneous injection. The specific dose should be determined by medical professionals based on factors such as the patient's age, weight, overall health status and severity of the disease.

Safety: The short half-life of ARA-290 plus the reduced expression of innate repair receptors constitute a dual safety system to avoid potential side effects.